Search for: "BRISTOL-MYERS SQUIBB"
Results 661 - 680
of 866
Sort by Relevance
|
Sort by Date
28 Feb 2010, 3:17 pm
The Food and Drug Administration says, “an organ transplant drug from Bristol-Myers Squibb improves kidney function, but the agency has concerns about potentially fatal side effects. [read post]
27 Feb 2010, 6:24 am
Cir. 1992); Bristol-Myers Squibb Co. v. [read post]
22 Feb 2010, 7:42 am
With Bristol-Myers and Windstream, at least 47 U.S. [read post]
17 Feb 2010, 4:55 pm
Several years later, two of Abbott's competitors (GSK and Bristol-Myers Squibb) introduced two new PIs which were meant to be used in conjunction with booster quantities of Norvir. [read post]
16 Feb 2010, 4:31 am
In addition, Time Warner, Genzyme, Bristol-Myers Squibb, International Paper, Pinnacle West Capital, and Liz Claiborne Inc. have filed similar no-action requests to exclude proposals with a 10 percent threshold, according to investors. [read post]
9 Feb 2010, 7:59 am
§1832, from his employer Bristol-Myers-Squibb, where he worked from November 2007 through February 2, 2010. [read post]
7 Feb 2010, 11:28 pm
See Bristol-Myers Squibb Co. v. [read post]
4 Feb 2010, 7:31 am
Jhaveri, a native of India, was a Technical Operations Associate with Bristol-Myers-Squibb for a little over two years until he was fired. [read post]
4 Feb 2010, 7:31 am
Jhaveri, a native of India, was a Technical Operations Associate with Bristol-Myers-Squibb for a little over two years until he was fired." [read post]
3 Feb 2010, 2:39 am
Didanosine, marketed by Bristol-Myers Squibb under the brand names Videx and Videx EC (an extended release version), was approved by the FDA in 1991, joining AZT as the only drugs then approved to treat HIV. [read post]
3 Feb 2010, 2:00 am
(Docket Report) Sustiva (Efavirenz) – US: Mylan and Matrix fail in bid to dismiss Sustiva case brought by Bristol Myer Squibb (Patent Docs) Temodar (Temozolomide) – US: District Court Delaware: Temador patent unenforceable due to prosecution laches and inequitable conduct: Cancer Research Tech v Barr Labs (Docket Report) (Patent Baristas) (IP Factor) Viread (Tenofovir) – US: Gilead Sciences announces notification of Teva’s ANDA filing for Viread… [read post]
28 Jan 2010, 7:19 am
A reminder that correlation does not imply causality: Derek Lowe of Corante’s ‘In the Pipeline’ (a drug-discovery blog) points to this graph in an article by Bristol-Myers Squibb’s Stephen Johnson, titled, The Trouble with QSAR (OR How I Stopped Worrying and Embrace Fallacy). [read post]
27 Jan 2010, 9:04 pm
District Court for the District of Delaware has ruled that Bristol-Myers Squibb may proceed with its patent infringement suit against defendants Mylan Pharmaceuticals and Matrix Laboratories over Bristol-Myers' patent covering the HIV treatment Sustiva®, U.S. [read post]
20 Jan 2010, 10:36 am
In addition, Time Warner, Genzyme, Bristol-Myers Squibb, International Paper, Pinnacle West Capital, and Liz Claiborne Inc. have filed similar no-action requests to exclude proposals with a 10 percent threshold, according to investors. [read post]
12 Jan 2010, 8:08 am
Bristol-Myers Squibb Co., No. 06-5203 (FLW), 2009 U.S. [read post]
6 Jan 2010, 6:00 am
Bristol-Myers Squibb Co., 2009 U.S. [read post]
6 Jan 2010, 3:10 am
” In re Bristol-Myers Squibb Co., 975 S.W.2d 601, 603 (Tex. 1998). [read post]
18 Dec 2009, 9:59 am
12/2: Bristol-Myers Squibb Company, Bristol-Myers Squibb Company, Novartis Corporation, et al. v. [read post]
9 Dec 2009, 3:59 pm
(Patent Docs) (SmartBrief) (GenericsWeb) OxyContin (Oxycodone) – US: Ranbaxy admits infringement in OxyContin suit – District Court S D New York approves consent judgment between Ranbaxy and Purdue Pharma (Patent Docs) Reyataz (Atazanavir) – US: Complaint filed in Delaware: Infringement of US patent following a Paragraph IV challenge: Bristol-Myers Squibb Co. et al. v. [read post]
7 Dec 2009, 4:04 am
Bristol-Myers Squibb, winner of a 2009 Employers of Choice commendation from Diversity & the Bar, Vol. 11, Nov. [read post]
